Unknown

Dataset Information

Insulin treatment normalizes retinal neuroinflammation but not markers of synapse loss in diabetic rats.


ABSTRACT: Diabetic retinopathy is one of the leading causes of blindness in developed countries, and a majority of patients with type I and type II diabetes will develop some degree of vision loss despite blood glucose control regimens. The effects of different insulin therapy regimens on early metabolic, inflammatory and neuronal retinal disease processes such as retinal neuroinflammation and synapse loss have not been extensively investigated. This study compared 3 months non-diabetic and streptozotocin (STZ)-induced diabetic Sprague Dawley rats. Diabetic rats received either no insulin treatment, systemic insulin treatment beginning after 1 week uncontrolled diabetes (early intervention, 11 weeks on insulin), or after 1.5 months uncontrolled diabetes (late intervention, 6 weeks on insulin). Chang

SUBMITTER: Masser DR 

PROVIDER: S-EPMC4122586 | biostudies-literature | 2014 Aug

REPOSITORIES: biostudies-literature